You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DHODH inhibitor

Showing 1 - 25 of 7,365
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Las Vegas, Fargo (RP7214, Placebo)

Completed
  • Healthy Volunteers
  • Las Vegas, Nevada
  • +1 more
Aug 17, 2021

SARS-CoV-2 Infection Trial in India (RP7214 + Standard of care (SOC), Placebo + Standard of care (SOC))

Completed
  • SARS-CoV-2 Infection
  • RP7214 + Standard of care (SOC)
  • Placebo + Standard of care (SOC)
  • Bangalore, India
  • +15 more
Apr 20, 2022

Dry Eye Disease Trial (KIO-101)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Nov 17, 2022

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial (RP7214)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Aug 17, 2022

Leukemia Trial in France, United States (BAY2402234)

Terminated
  • Leukemia
  • Bronx, New York
  • +4 more
Dec 20, 2021

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Worldwide (JNJ-74856665, AZA, VEN)

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +22 more
Jan 27, 2023

COVID-19 Trial in Chertsey (leflunomide)

Active, not recruiting
  • COVID-19
  • Chertsey, United Kingdom
    Ashford and St Peters Hospital NHS Foundation Trust
Aug 12, 2021

COVID-19 Trial in India (Brequinar Sodium, Dipyridamole 75 MG, Placebo)

Terminated
  • COVID-19
  • Brequinar Sodium
  • +2 more
  • Srikakulam, Andhra Pradesh, India
  • +6 more
Jun 16, 2022

Alopecia Areata Trial in United States (Farudodstat, Placebo)

Recruiting
  • Alopecia Areata
  • Birmingham, Alabama
  • +18 more
May 23, 2023

Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

Terminated
  • Leukemia, Myeloid, Acute
  • AML
  • Aurora, Colorado
  • +16 more
Jan 18, 2022

COVID-19 Infection Trial in United States (Brequinar, Placebo)

Completed
Has Results
  • COVID-19 Infection
  • Homewood, Alabama
  • +13 more
Apr 14, 2022

COVID-19 Trial in United States (Brequinar, Standard of Care)

Completed
Has Results
  • COVID-19
  • Hartford, Connecticut
  • +4 more
Feb 15, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (IMU-838 tablets, Placebo matching IMU-838 tablets)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • IMU-838 tablets
  • Placebo matching IMU-838 tablets
  • Altamonte Springs, Florida
  • +28 more
Jul 29, 2022

MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)

Not yet recruiting
  • MEN1 Gene Mutation
  • Leflunomide 20 mg
  • Basel, Switzerland
    Unispital Basel
Nov 1, 2022

Multiple Sclerosis Trial in Worldwide (IMU-838 tablets, Placebo matching IMU-838 tablets)

Recruiting
  • Multiple Sclerosis
  • IMU-838 tablets
  • Placebo matching IMU-838 tablets
  • Phoenix, Arizona
  • +58 more
Jan 31, 2023

Lymphoma Trial in United States (AG-636)

Terminated
  • Lymphoma
  • New Haven, Connecticut
  • +5 more
Aug 21, 2020

Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Peripheral T Cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing/China, China
  • +1 more
Oct 9, 2023

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

Not yet recruiting
  • Cervical Cancer
  • Anti-PD-1 antibody balstilimab
  • Amsterdam, Netherlands
    Amsterdam UMC
Oct 17, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

Not yet recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Aug 21, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

Not yet recruiting
  • Chronic Kidney Disease
  • Part A - Lorundrostat QD + Dapaglifozin QD
  • +2 more
  • (no location specified)
Nov 27, 2023

Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Pavia, Lombardia, Italy
    Istituti Clinici Scientifici Maugeri
May 5, 2023

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023